Cargando…

UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma

PURPOSE: As a member of the ubiquitin‐conjugating enzyme (E2) family, UBE2V2 demonstrates significant tumorigenicity in many cancers. However, the relationship between UBE2V2 expression and the morbidity of lung adenocarcinoma (LUAD) is still unknown. METHODS: We detected the mRNA and protein expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zheng, Wu, Gujie, Zhao, Jianmei, Shi, Guanglin, Zhou, Juan, Zhou, Xiaoyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587983/ https://www.ncbi.nlm.nih.gov/pubmed/37755128 http://dx.doi.org/10.1002/cam4.6566

Ejemplares similares

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

GPR115 Contributes to Lung Adenocarcinoma Metastasis Associated With LAMC2 and Predicts a Poor Prognosis
por: Wang, Yingjing, et al.
Publicado: (2020)

Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
por: Yen, Meng-Chi, et al.
Publicado: (2021)

UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
por: Liu, Zhi, et al.
Publicado: (2018)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
por: Zhang, Jiguang, et al.
Publicado: (2022)

CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis
por: Truesdell, P, et al.
Publicado: (2014)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT
por: Huang, Peng, et al.
Publicado: (2020)

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non‐small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2017)

Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
por: Ren, Xiaoyue, et al.
Publicado: (2021)

SP1 transcriptionally regulates UBE2N expression to promote lung adenocarcinoma progression
por: Li, Jianjun, et al.
Publicado: (2023)

SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition
por: Chen, Xin, et al.
Publicado: (2017)

PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma
por: Dong, Chenglai, et al.
Publicado: (2022)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma
por: Xu, Yinhai, et al.
Publicado: (2021)

Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021)

Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma
por: Xu, Feng, et al.
Publicado: (2022)

LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in gastric cancer
por: Wei, Yucai, et al.
Publicado: (2019)

UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop
por: Liu, Xu, et al.
Publicado: (2020)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
por: Zhu, Jinhong, et al.
Publicado: (2021)

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma
por: Du, Renle, et al.
Publicado: (2023)

Corrigendum: Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2022)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma
por: Wang, Xiaoxia, et al.
Publicado: (2018)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT
por: He, Zhen-Yu, et al.
Publicado: (2016)

Overexpression of P4HA1 associates with poor prognosis and promotes cell proliferation and metastasis of lung adenocarcinoma
por: Ning, Yue, et al.
Publicado: (2021)

Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure
por: Hu, Na, et al.
Publicado: (2021)

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma
por: Zhan, Ping, et al.
Publicado: (2016)

TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
por: Zhou, Fang, et al.
Publicado: (2020)

Reduced Expression of ZDHHC2 Is Associated with Lymph Node Metastasis and Poor Prognosis in Gastric Adenocarcinoma
por: Yan, Shu-Mei, et al.
Publicado: (2013)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2018)

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Seok, Yangki, et al.
Publicado: (2019)

Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy
por: Shen, Tong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_48oe8evhh90loaurboccsned6j